Structures by: Wang B. Z.
Total: 11
1,1-Difluoro-3-phenyl-9-(pyridin-2-yl)-1<i>H</i>-1λ^4^,11λ^4^-1,3,5,2-oxadiazaborinino[3,4-<i>a</i>][1,8]naphthyridine
C20H13BF2N4O
IUCrData (2016) 1, 7 x161129
a=10.144(2)Å b=16.276(3)Å c=10.491(2)Å
α=90.00° β=101.27(3)° γ=90.00°
C21H23N3O3S
C21H23N3O3S
Med. Chem. Commun. (2016) 7, 9 1759
a=22.120(3)Å b=11.7114(16)Å c=16.324(2)Å
α=90.00° β=109.222(4)° γ=90.00°
6o
C21H20BrN3O2
RSC Adv. (2016) 6, 36 30412
a=16.5763(14)Å b=8.0259(7)Å c=15.6946(13)Å
α=90.00° β=109.896(2)° γ=90.00°
C54H8Ag16N110O27
C54H8Ag16N110O27
Dalton transactions (Cambridge, England : 2003) (2016) 45, 16 6968-6973
a=15.3657(4)Å b=15.3657(4)Å c=17.7122(5)Å
α=90.00° β=90.00° γ=120.00°
<i>N</i>-(7-Dibromomethyl-5-methyl-1,8-naphthyridin-2-yl)benzamide--pyrrolidine-2,5-dione (1/1)
C17H13Br2N3O1,C4H5NO2
Acta Crystallographica Section E (2017) 73, 1 1-3
a=9.6931(19)Å b=15.699(3)Å c=14.614(3)Å
α=90.00° β=108.99(3)° γ=90.00°
9-(Dibromomethyl)-1,1-difluoro-3,7-dimethyl-1<i>H</i>-[1,3,5,2]oxadiazaborinino[3,4-<i>a</i>][1,8]naphthyridin-11-ium-1-uide
C12H10BBr2F2N3O
Acta Crystallographica Section E (2016) 72, 11 1642-1644
a=17.161(3)Å b=7.2169(14)Å c=11.678(2)Å
α=90.00° β=90.00° γ=90.00°
Bifurazano[3,4-<i>b</i>:3',4'-<i>f</i>]furoxano[3'',4''- <i>d</i>]oxacyclohetpatriene
C6N6O5,H2O
Acta Crystallographica Section E (2012) 68, 3 o869
a=9.324(4)Å b=9.727(4)Å c=10.391(4)Å
α=90.00° β=106.305(6)° γ=90.00°
Diethyl 2,2'-bis(hydroxyimino)-3,3'-(hydrazinediylidene)dibutanoate
C12H18N4O6
Acta Crystallographica Section E (2012) 68, 3 o842
a=10.8587(11)Å b=8.3068(9)Å c=8.8465(9)Å
α=90.00° β=99.782(2)° γ=90.00°
Carbamoyl(diaminomethylidene)azanium 3-nitro-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-4-ide
C2H7N4O,C2HN4O3
Acta Crystallographica Section E (2013) 69, 7 o1086
a=3.7100(5)Å b=13.4195(19)Å c=18.033(3)Å
α=90.00° β=94.143(3)° γ=90.00°
4-[4-(4-Amino-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3- amine
C6H4N8O3
Acta Crystallographica Section E (2012) 68, 5 o1573
a=7.1681(9)Å b=10.8147(13)Å c=12.3448(18)Å
α=90.00° β=103.1550(10)° γ=90.00°
2-<i>tert</i>-Butyl-1-(4-nitroamino-1,2,5-oxadiazol-3-yl)diazene 1-oxide
C6H10N6O4
Acta Crystallographica Section E (2012) 68, 7 o2171
a=6.2509(5)Å b=9.1327(8)Å c=18.6566(16)Å
α=90.00° β=92.134(2)° γ=90.00°